₹68
■ +0 +0.00%
30 Jul 2026
NSE Listed · Healthcare
Aakaar Medical Technologies Ltd. (AAKAAR)
Volume: 0Avg Vol 1W: 2,880Avg Vol 1M: 7,92752W Range:₹46₹98.8
Key Ratios
Checked 6h agoMarket Cap—
Current Price₹68
Previous Close₹68
High / Low (52w)₹98.8 / ₹46
Volume0
Avg Vol (1W)2,880
Avg Vol (1M)7,927
Stock P/E14.53
Book Value₹38.49
Dividend Yield0%
ROE12.17%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹4.68
P/B1.77
Debt / Equity0.53
50 DMA₹70.37
200 DMA₹69.28
Day change+0.00%
Price Chart
₹68▼ 21.93% · 1Y
2025-07-302026-07-30
20-day avg volume: 7K shares
Pros
- Company is almost debt-free.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹23 Cr | ₹13 Cr | ₹20 Cr | ₹33 Cr | ₹46 Cr | ₹62 Cr | ₹68 Cr |
| EBITDA | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹10 Cr | ₹11 Cr |
| Net Profit | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹6 Cr | ₹7 Cr |
| EPS | 182.79 | 54.44 | 1.78 | 2.37 | 3.15 | 6.12 | 4.99 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹16 Cr | ₹14 Cr | ₹18 Cr | ₹23 Cr | ₹34 Cr | ₹54 Cr | ₹79 Cr |
| Total Liabilities | ₹9 Cr | ₹7 Cr | ₹10 Cr | ₹14 Cr | ₹21 Cr | ₹31 Cr | ₹25 Cr |
| Equity | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹10 Cr | ₹13 Cr | ₹23 Cr | ₹55 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹5 Cr | ₹1 Cr | ₹-2 Cr | ₹-7 Cr | ₹-3 Cr | ₹-6 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹-2 Cr | ₹-1 Cr | ₹1 Cr | ₹8 Cr | ₹11 Cr | ₹19 Cr |
| Free Cash Flow | ₹5 Cr | ₹1 Cr | ₹-2 Cr | ₹-7 Cr | ₹-3 Cr | ₹-6 Cr |
Shareholding
Promoter 67.05% Institutions 11.17% Public 21.78%
Efficiency & Working Capital
ROCE26%
Interest Coverage6.1
Dividend Payout—
Debtor Days203 d
Inventory Days108 d
Payable Days10 d
Cash Conversion Cycle300 d
Working Capital Days311 d
Shareholding Details
As of 2026-03-31
Promoter67.1%
FII0%
DII11.2%
Institutions11.2%
Public21.8%
Promoter Pledge0%
No. of Shareholders550
Shareholding Pattern
Quarterly — figures in %. Latest 4 quarters.
| Period | Feb 2025 | Jun 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoters | 91.1% | 67% | 67% | 67.1% |
| FIIs | 0% | 1.9% | 0.5% | 0% |
| DIIs | 0% | 0% | 0% | 11.2% |
| Public | 8.9% | 31.1% | 32.5% | 21.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% |
| No. of Shareholders | 11 | 920 | 603 | 550 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Dilip Ramesh Meswani | Shareholding of Promoter and Promoter Group | 48.2% | 68,31,400 |
| Bindi Dilip Meswani | Shareholding of Promoter and Promoter Group | 12.8% | 18,20,000 |
| India Equity Fund 1 | Public Shareholding | 5% | 7,04,000 |
| Rahul B Sawakhande | Public Shareholding | 4.1% | 5,80,853 |
| Aarth Aif Growth Fund | Public Shareholding | 3.6% | 5,12,000 |
| Abhash Meswani | Shareholding of Promoter and Promoter Group | 2.5% | 3,54,900 |
| Sharda Rameshchandra Meswani | Shareholding of Promoter and Promoter Group | 2% | 2,85,769 |
| Milouni Dilip Meswani | Shareholding of Promoter and Promoter Group | 1.5% | 2,10,844 |
| Chaitanya Gadia | Public Shareholding | 1.2% | 1,69,600 |
| Grobiz Sme Opportunity Fund | Public Shareholding | 1.1% | 1,56,250 |
| Mitesh Meswani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rita Prasad Meswani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Priti Parikh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Jasuben Himatlal Dani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Paresh Himmatlal Dani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dilip Meswani Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Revigen Medicare Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Coherent Medical Systems | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aesthetic Solutions-huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Bindi Dilip Meswani | Chairperson | 2026 |
| Dilip Ramesh Meswani | Founder / Managing Director | 2026 |
| Rahul Babasaheb Sawakhande | Executive Director & CEO | 2026 |
| Rajendra Indubhai Dhandhukia | Independent Non Exe. Director | 2026 |
| Deepanjan Periwal | Independent Non Exe. Director | 2026 |
| Anoopkumar Pillai | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Aesthetic Devices & Device consumab | ₹7 Cr | 11% |
| Aesthetic Products | ₹60 Cr | 89% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 15 | 14 | 14 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 5 | 0 | 6 |
| 2026 | 0 | 0 | 0 | 2 | 0 | 3 |
| 2026 | 0 | 0 | 0 | 2 | 0 | 2 |
Company Information
Incorporated2013
ChairmanBindi Dilip Meswani
AuditorC B Mehta & Associates
Investor Email[email protected]
📍 No.801 Heritage Plaza, Telli Galli Cross Rd Andher E, Mumbai, Maharashtra, 400069
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
AAFS MARKET LINKED 2031Aafs Mkt Lkd 2031 Car- LimitedAafs Market Linked 2032AAFS MKT LKD 2032 CAR MAAFS MARKET LINK2034 SRBAAFS MARKET LINKED 2034Aakash Exploration Services Ltd.Aaradhya Disposal Industries Ltd.Aarey Drugs & Pharmaceuticals Ltd.Aarnav Fashions LimitedAaron Industries LimitedAartech Solonics LimitedAll “A” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search